Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
STRAP.COthis companyStrategic Partners A/S	DKK 590.00	-33.24×	1.58×	94.22×	-11.74×	-95.0%	100.0%	-791.6%	-278.0%	-4.7%	-13.3%	-7.3%	0×	0.16×	0×	13.9×	0.0%	6	22.59	3	B
AMBU-B.COAmbu A/S	DKK 86.90	40.44×	4.09×	4.09×	21.05×	-90.1%	56.0%	13.0%	10.1%	10.1%	9.6%	2.7%	0.09×	-0.28×	26.13×	2.72×	0.4%	7	9.53	3	B
BAVA.COBavarian Nordic A/S	DKK 246.80	10.83×	1.16×	2.41×	8.14×	-689.9%	47.4%	14.9%	22.3%	10.7%	5.2%	9.2%	0.01×	-0.97×	70.08×	4.22×	0.0%	7	9.87	5	A+
BIOPOR.COBioPorto A/S	DKK 1.00	-6.8×	8.7×	13.61×	-5.92×	-186.0%	69.5%	-213.7%	-203.8%	-130.3%	-114.4%	-14.1%	0.12×	0.56×	-111.52×	3.25×	0.0%	3	5.54	3	B-
GMAB.COGenmab A/S	DKK 3,661.00	126.06×	21.59×	32.64×	94.9×	-90.7%	91.7%	33.6%	25.9%	17.1%	8.9%	0.9%	0.95×	2.8×	20.49×	2.02×	0.0%	6	22.57	2	C+
ZEAL.COZealand Pharma A/S	DKK 245.00	5.09×	2.22×	3.57×	4×	-647.0%	99.7%	77.7%	70.0%	43.5%	41.7%	19.8%	0.03×	-0.58×	189.81×	23.57×	0.0%	3	7.44	4	A
Peer median	—	10.83×	4.09×	4.09×	8.14×	-186.0%	69.5%	14.9%	22.3%	10.7%	8.9%	2.7%	0.09×	-0.28×	26.13×	3.25×	0.0%	6	9.53	3	—